Tellus Therapeutics, Inc
Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Tellus' lead candidate, TT-20, induces regeneration of myelin-producing oligodendrocytes, reverses white matter injury in an animal models of perinatal brain injury and multiple sclerosis and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury.
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
90
organic / mo
Sign up free to see all 7 verified contacts at Tellus Therapeutics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
- KA
Khadar Abdi
Director of Research · Research & Development
EmailPhone - LK
Lilia Koza
Scientist · Science
EmailPhone - AS
Austin Schwartz
VP of Operations and Finance · Other
EmailPhone - JB
Jaron Ballentine
VP Clinical Operations and Business Development · Other
EmailPhone - EB
Eric Benner
Co-founder, Chief Scientific Officer · Other
EmailPhone
Showing 5 of 7 verified contacts
Top roles at Tellus Therapeutics, Inc
6 distinct titles indexed · top 6 shown.
- 1business development intern
- 1co-founder, chief scientific officer
- 1director of research
- 1scientist
- 1vp clinical operations and business development
- 1vp of operations and finance
Sign up to unlock all 7 contacts at Tellus Therapeutics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Tellus Therapeutics, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.